We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Supply Threatened by Tickborne Parasite

By LabMedica International staff writers
Posted on 22 Sep 2011
Blood supplies in the US and other countries are becoming increasingly infected with Babesia, a tickborne parasite of red blood cells.

A number of medical device and diagnostic companies are working on developing tests for Babesia for donor-screening purposes, as there is an urgent need for a screening test and prevention strategies. More...


Medical epidemiologists at the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) have tracked case-patients who were transfused during 1979–2009 and had post transfusion babesiosis diagnosed by 2010, without reported evidence that another transmission route was more likely than transfusion. Implicated donors had laboratory evidence of infection by immunofluorescence antibody tests (IFA), blood films, or polymerase chain reaction (PCR) assays.

The scientists found 159 Babesia microti transfusion-associated cases and donors were implicated for 136 (86%). The case-patients' median age was 65 years with a range from less than a year old to 94 years. Most cases were associated with red blood cell components, but four were linked to whole blood–derived platelets. Cases occurred in all four seasons, and in 22 of the 31 years studied. However, 77% of the cases were reported during 2000-2009. Cases occurred in 19 US states, yet 138 cases were in the seven main B. microti–endemic states. In addition, three cases due to B. duncani were documented in western states. Among the 117 linked donors, the B. microti IFA-test results were known; 24 donors (20%) had parasitologically confirmed infection by blood films; and 20 donors had positive PCR results.

Babesiosis is a parasitic disease, very similar to malaria, and is caused by Babesia, a protozoan parasite of the blood. Babesia parasites are believed to be the second most common blood parasites of mammals, after trypanosomes. Although much less common in humans than other mammals, experts say reported human cases have risen over the last decade mainly because of better medical awareness. Babesiosis is a potentially life-threatening complication of blood transfusion, but it is treatable. An infected individual has a risk of multi-organ failure, and even death. Patients without a spleen, individuals with weakened immune systems, and the elderly are more vulnerable to complications.

Barbara Herwaldt, MD, MPH, from the CDC and lead author of the study, said, "We want clinicians to become more aware of babesiosis, including the small possibility of transmission via blood transfusion. If a patient develops unexplained fever or hemolytic anemia after a transfusion, babesiosis should be considered as a possible cause, regardless of the season or US region." Most cases in Europe have involved splenectomized patients and 50% of European cases were fatal. The study was published September 5, 2011 in the Annals of Internal Medicine.

Related Links:
US Centers for Disease Control and Prevention



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.